Polycythemia Vera (PV) is a rare chronic blood disorder characterized by the overproduction of red blood cells in the bone marrow. It falls under the category of myeloproliferative neoplasms, which are a group of blood cancers.
The prevalence of PV varies across different populations and regions. In the United States, the estimated prevalence of PV is approximately 44 to 57 cases per 100,000 individuals. It is more commonly diagnosed in individuals over the age of 60, with a slightly higher incidence in males than females.
While PV is considered a rare condition, it is important to note that the prevalence may be underestimated due to underdiagnosis or misdiagnosis. Many individuals with PV may remain asymptomatic or exhibit mild symptoms, leading to delayed diagnosis or misclassification.
Early detection and proper management of PV are crucial to prevent complications such as blood clots, stroke, or heart problems. Regular monitoring and treatment by a hematologist are recommended for individuals diagnosed with PV.